scispace - formally typeset
H

Hiromi Hagiwara

Researcher at Toin University of Yokohama

Publications -  54
Citations -  2053

Hiromi Hagiwara is an academic researcher from Toin University of Yokohama. The author has contributed to research in topics: Osteoblast & Osteoclast. The author has an hindex of 24, co-authored 54 publications receiving 1912 citations. Previous affiliations of Hiromi Hagiwara include Tokyo Institute of Technology.

Papers
More filters
Journal ArticleDOI

Characterization of osteoblastic differentiation of stromal cell line ST2 that is induced by ascorbic acid

TL;DR: The results suggest that ascorbic acid might promote the differentiation of ST2 cells into osteoblast-like cells by inducing the formation of a matrix of type I collagen, with subsequent activation of the signaling pathways that involve BMPs.
Journal ArticleDOI

Excess iron inhibits osteoblast metabolism.

TL;DR: It is suggested that iron overload might give rise to osteoporosis by inhibiting osteoblast proliferation and differentiation, as well as the expression of type I collagen and protein and the activity of alkaline phosphatase.
Journal ArticleDOI

Olive polyphenol hydroxytyrosol prevents bone loss

TL;DR: The findings indicate that the olive polyphenols oleuropein and hydroxytyrosol may have critical effects on the formation and maintenance of bone, and can be used as effective remedies in the treatment of osteoporosis symptoms.
Journal ArticleDOI

Quercetin suppresses bone resorption by inhibiting the differentiation and activation of osteoclasts.

TL;DR: The results suggest that osteoclast progenitors as well as mature osteoclasts, are quercetin's target cells in relation to bone resorption, and that quercETin's suppressive effect on bone Resorption results from both its inhibitory effect on the differentiation of osteoc last progenitor cells into pOCs and from its disruptive effect on actin rings in mature osteclasts.
Journal ArticleDOI

Endothelin B receptors are expressed by astrocytes and regulate astrocyte hypertrophy in the normal and injured CNS.

TL;DR: The data suggest that pharmacological blockade of astrocyte ETBR receptors following CNS injury modulates glial scar formation and may provide a more permissive substrate for neuronal survival and regeneration.